| Name | Bcl-2-IN-11 | 
|---|
| Description | Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. Bcl-2-IN-11 shows weak inhibition of Bcl-xl (IC50 > 1000 nM). Bcl-2-IN-11 can be used for the research of a variety of cancers caused by abnormal overexpression of Bcl-2 family proteins: especially malignant hematologic diseases of acute lymphoid leukemia, etc. Bcl-2-IN-11 can also avoid toxic side effects caused by Bcl-xl inhibition, such as thrombocytopenia[1]. | 
|---|---|
| Related Catalog | |
| Target | Bcl-2:0.9 nM (IC50) Bcl-xL:>1000 nM (IC50) | 
| References | [1]. Kong Xianglong, et al. Heterocyclic compound as bcl-2 inhibitor. WO2022028353A1. | 
| Molecular Formula | C45H49ClFN7O8S | 
|---|---|
| Molecular Weight | 902.43 |